Why is Senores Pharma. falling/rising?

As of 23-Sep, Senores Pharmaceuticals Ltd is experiencing a price increase, currently at 715.60, which reflects a rise of 8.3 or 1.17%. The stock has shown a positive trend today, outperforming its sector by 1.52% and gaining after two consecutive days of decline. It is currently trading close to its 52-week high, just 4.9% away from Rs 750.65. The stock has demonstrated strong performance over the past week with a return of +4.57%, although it has seen a slight decline of -1.12% over the past month. The company has a low debt-to-equity ratio and has reported impressive growth in net sales and operating profit, contributing to positive investor sentiment.
In the broader market context, while Senores Pharmaceuticals has outperformed the Sensex in the short term, the benchmark has shown a slight decline of -0.34% over the past week. Despite the stock's positive performance, there are concerns regarding falling participation from institutional investors, who have reduced their stake by -0.65% in the previous quarter. This decline in institutional interest may indicate a cautious outlook among more experienced investors, contrasting with the stock's recent gains. Overall, while the stock is rising due to strong fundamentals and positive short-term performance, the decrease in institutional investment could pose challenges moving forward.